Secondary amenorrhoea due to the use of rifampicin as an antimycobacterial agent.
Swanton
A G
AG
Queen Charlottes and Chelsea Hospital, Ducane Road, London W12 0NN, UK.
Paterson-Brown
S
S
D000328:Adult; D000568:Amenorrhea / Q000139:chemically induced* / Q000188:drug therapy; D000904:Antibiotics, Antitubercular / Q000009:adverse effects* / Q000627:therapeutic use; D003940:Diagnostic Techniques, Endocrine; D005260:Female; D006801:Humans; D009333:Neck; D009640:Norethindrone / Q000627:therapeutic use; D045167:Progesterone Congeners / Q000627:therapeutic use; D012293:Rifampin / Q000009:adverse effects* / Q000627:therapeutic use; D018461:Soft Tissue Infections / Q000188:drug therapy; D016896:Treatment Outcome; D014375:Tuberculoma / Q000188:drug therapy*
D000904:Antibiotics, Antitubercular; D045167:Progesterone Congeners; D009640:Norethindrone; D012293:Rifampin